MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-09-2026
Anavex Life Sciences Corp. Depreciation & Amortization 2011-2026 | AVXL
Annual Depreciation & Amortization Anavex Life Sciences Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 1.25 K | 995 | 768 | 576 | 1.86 K | 1.66 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.86 K | 576 | 1.18 K |
Quarterly Depreciation & Amortization Anavex Life Sciences Corp.
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 746 | 497 | - | 249 | 746 | 498 | 249 | 249 | 576 | 384 | - | 192 | 576 | - | 192 | 465 | 1.39 K | 465 | 465 | 464 | 1.28 K | 377 | 464 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.39 K | 192 | 526 |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M |  USA |
 |
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | USA |
 |
ADMA Biologics
ADMA
|
8 M | $ 15.6 | -5.71 % | $ 3.72 B | USA |
 |
AgeX Therapeutics
AGE
|
131 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | USA |
 |
AbCellera Biologics
ABCL
|
18.4 M | $ 3.55 | -2.34 % | $ 1.06 B |  Canada |
 |
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M |  China |
 |
Aptorum Group Limited
APM
|
1.13 M | $ 0.82 | -0.73 % | $ 4.47 M | China |
 |
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | USA |
 |
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
1.56 M | $ 20.14 | 1.41 % | $ 2.54 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
67.7 M | $ 75.28 | -1.63 % | $ 1.45 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.47 | -9.81 % | $ 375 M |  Britain |
 |
Aravive
ARAV
|
886 K | - | -13.39 % | $ 1.45 M | USA |
 |
Adverum Biotechnologies
ADVM
|
3.65 M | - | - | $ 86.2 M | USA |
 |
Athersys
ATHX
|
1.43 M | - | 3.77 % | $ 22.4 M | USA |
 |
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | USA |
 |
AVEO Pharmaceuticals
AVEO
|
67 K | - | - | $ 521 M | USA |
 |
Axsome Therapeutics
AXSM
|
503 K | $ 160.48 | -2.19 % | $ 7.98 B | USA |
 |
BridgeBio Pharma
BBIO
|
5.43 M | $ 65.44 | -1.65 % | $ 12.5 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
240 K | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | USA |
 |
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
142 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
11 K | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | USA |
 |
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | Canada |
 |
BioMarin Pharmaceutical
BMRN
|
79.6 M | $ 60.53 | 0.17 % | $ 11.6 B | USA |
 |
Cabaletta Bio
CABA
|
1.43 M | $ 3.19 | -7.14 % | $ 3.73 M | USA |
 |
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | USA |
 |
Agenus
AGEN
|
13.6 M | $ 2.98 | -7.03 % | $ 1.07 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M |  Israel |
 |
Capricor Therapeutics
CAPR
|
1.07 M | $ 25.34 | -0.65 % | $ 679 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
1.15 M | $ 34.35 | -3.75 % | $ 3.57 B | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
641 K | $ 8.02 | -4.75 % | $ 34.7 M | USA |